{
    "2019-09-20": [
        [
            {
                "time": "2019-09-20",
                "original_text": "[快讯]9月20日大宗交易一览",
                "features": {
                    "keywords": [
                        "大宗交易",
                        "复星医药"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "复星医药今日大宗交易成交29万股，成交价27.47元折价1.89%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "齐鲁大爆发！17个过评品种霸屏，5个“4+7”品种迎战集采，21个注射剂发力",
                "features": {
                    "keywords": [
                        "齐鲁",
                        "过评品种",
                        "集采",
                        "注射剂"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "宏信证券：每日信息速递",
                "features": {
                    "keywords": [
                        "宏信证券",
                        "每日信息"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "复星医药赴港分拆上市 募资规模超30亿港元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "分拆上市",
                        "募资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "子公司分拆上市白云山冲刺千亿市值",
                "features": {
                    "keywords": [
                        "子公司",
                        "分拆上市",
                        "白云山",
                        "市值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "今年最重磅医药IPO：复宏汉霖拟下周赴港上市，10年未盈利",
                "features": {
                    "keywords": [
                        "复宏汉霖",
                        "IPO",
                        "未盈利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "提前埋伏 后面还有利好要兑现！",
                "features": {
                    "keywords": [
                        "埋伏",
                        "利好"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "复星医药(02196-HK)获控股股东增持106万股",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股股东",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "复星医药分拆上市再进一步 复宏汉霖IPO募资有望超30亿港元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "分拆上市",
                        "复宏汉霖",
                        "IPO",
                        "募资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "周五最新重磅公司传闻集锦(9月20日)",
                "features": {
                    "keywords": [
                        "公司传闻",
                        "集锦"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}